Baixar PDF
1 / Páginas

Outros usuários também visualizaram estes artigos

Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial Saghar Barati; Hossein Amini; Zargham Hossein Ahmadi; Alireza Dastan; Babak Sharif Kashani; Raha Eskandari; Farzaneh Dastan;
Rev Port Cardiol. 2023;42:139-44
Effect of direct oral anticoagulants versus vitamin K antagonists or warfarin in patients with left ventricular thrombus outcomes: A systematic review and meta-analysis Hilaryano da Silva Ferreira; Joana Lima Lopes; João Augusto; Joana Simões; David Roque; Daniel Faria; João Ferreira; Inês Fialho; Marco Beringuilho; Humberto Morais; Ana Rita Ferreira; José Morais; Carlos Morais;
Rev Port Cardiol. 2023;42:63-70
Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke Luís Paiva; José Coelho; Sérgio Barra; Marco Costa; João Sargento-Freitas; Luís Cunha; Lino Gonçalves;
Rev Port Cardiol. 2021;40:357-65